A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Not long after pledging to operate a digital bank in America, Spain’s most valuable lender is reevaluating its business in the UK.
The EU wants everyone to know it has no intention of genuflecting toward a new Trump administration and won’t stop doling out Big Tech fines.
After a brief blackout period from late Saturday, TikTok began restoring services to US users on Sunday morning.